Key Dates

Related Announcements

• April 24, 2024 - NIH Pathway to Independence Award (Parent K99/R00 – Independent Clinical Trial Required). See PA-24-193.
• April 24, 2024 - NIH Pathway to Independence Award (Parent K99/R00 – Independent Clinical Trial Not Allowed). See PA-24-194.
• April 24, 2024 - NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies with Humans Required). See PA-24-195.

Issued by

National Cancer Institute (NCI)

Purpose

This Notice informs potential NCI K99/R00 applicants that effective December 31st, 2024, NCI will no longer participate in:

• PA-24-193 - NIH Pathway to Independence Award (Parent K99/R00 – Independent Clinical Trial Required);
• PA-24-194 - NIH Pathway to Independence Award (Parent K99/R00 – Independent Clinical Trial Not Allowed); and 
• PA-24-195 - NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies with Humans Required). 

NCI will not accept any applications submitted in response to PA-24-193, PA-24-194 and PA-24-195 including resubmissions, after December 31, 2024.

To replace NCI's participation in the Parent K99/R00 program, NCI has issued the following Notices of Funding Opportunity (NOFO) PAR-25-135 NCI Pathway to Independence Award (K99/R00 - Independent Clinical Trial Not Allowed) and PAR-25-313 NCI Pathway to Independence Award (K99/R00 - Independent Clinical Trial Required) that expand the NCI K99 eligibility window from 4 to 6 years of postdoctoral research training experience. Please see https://www.cancer.gov/grants-training/training/funding/k99 for additional information.

Inquiries

Please direct all inquiries to:

Michael Schmidt, Ph.D.
National Cancer Institute (NCI)
Center for Cancer Training
Telephone: 240-460-6896
Email: [email protected]